Item request has been placed!

Item request cannot be made.

Processing Request

نتائج البحث

Display Settings

النتائج لكل صفحة: 10

Sort By: Relevance

Filter

فلترة النتائج

إعادة تعيين خيارات الفبترة

Item request has been placed!

Item request cannot be made.

Processing Request

Academic Journal

High-dose busulfan and thiotepa followed by autologous stem cell transplantation (ASCT) in previously irradiated medulloblastoma patients: high toxicity and lack of efficacy.

Authors : Valteau-Couanet, D.¹ ; Fillipini, B.¹; Benhamou, E.²

Source: Bone Marrow Transplantation. Dec2005, Vol. 36 Issue 11, p939-945. 7p. 4 Charts.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Randomized trial of two different conditioning regimens for bone marrow transplantation in thalassemia – the role of busulfan pharmacokinetics in determining outcome.

Authors : Chandy, M.¹ ; Balasubramanian, P.¹; Ramachandran, S. V.¹

Source: Bone Marrow Transplantation. Nov2005, Vol. 36 Issue 10, p839-845. 7p. 6 Diagrams, 1 Chart.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Accidental busulfan overdose during conditioning for stem cell transplantation.

Authors : Jenke, A.¹ ; Freiberg-Richter, J.¹; Wilhelm, S.²

Source: Bone Marrow Transplantation. Jan2005, Vol. 35 Issue 2, p125-128. 4p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Complete substitution of cyclophosphamide by fludarabine and ATG in a busulfan-based preparative regimen for children and adolescents with β-thalassemia.

Authors : Sauer, M.¹ ; Bettoni, C.¹; Lauten, M.¹

Source: Bone Marrow Transplantation. Sep2005, Vol. 36 Issue 5, p383-387. 5p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Modification of the Bu/Cy myeloablative regimen using daily parenteral busulfan: reduced toxicity without the need for pharmacokinetic monitoring.

Authors : Mamlouk, K^1,2; Saracino, G¹; Berryman, RB^1,3

Source: Bone Marrow Transplantation. Apr2005, Vol. 35 Issue 8, p747-754. 8p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

CD8+T-cell-depleted, matched unrelated donor, allogeneic bone marrow transplantation for advanced AML using busulfan-based preparative regimens.

Authors : Kalaycio, M¹ ; Rybicki, L²; Pohlman, B¹

Source: Bone Marrow Transplantation. Feb2005, Vol. 35 Issue 3, p247-252. 6p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Overexpression of Glutathione-S-Transferase, MGSTII, Confers Resistance to Busulfan and Melphalan.

Authors : Harkey, Michael A.^1,2 (AUTHOR); Czerwinski, Maciej¹ (AUTHOR); Slattery, John¹ (AUTHOR)

Source: Cancer Investigation. 2005, Vol. 23 Issue 1, p19-25. 7p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Intravenous busulfan in children prior to stem cell transplantation: study of pharmacokinetics in association with early clinical outcome and toxicity.

Authors : Zwaveling, J¹ ; Bredius, R G M²; Cremers, S C L M¹

Source: Bone Marrow Transplantation. Jan2005, Vol. 35 Issue 1, p17-23. 7p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

High-dose busulfan, cyclophosphamide, and etoposide does not improve outcome of allogeneic stem cell transplantation compared to BuCy2 in patients with acute myeloid leukemia.

Authors : Farag, S. S.¹ ; Bolwell, B. J.²; Elder, P. J.¹

Source: Bone Marrow Transplantation. Apr2005, Vol. 35 Issue 7, p653-661. 9p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Possible role of high-dose busulfan in second reciprocal transplant between brother and sister for resistant acute leukemia.

Authors : Nuara, M.¹; Vigano, E.¹; Longoni, D.¹

Source: Bone Marrow Transplantation. Apr2005, Vol. 35 Issue 7, p731-732. 2p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

نتائج البحث

فلترة النتائج

High-dose busulfan and thiotepa followed by autologous stem cell transplantation (ASCT) in previously irradiated medulloblastoma patients: high toxicity and lack of efficacy.

Randomized trial of two different conditioning regimens for bone marrow transplantation in thalassemia – the role of busulfan pharmacokinetics in determining outcome.

Accidental busulfan overdose during conditioning for stem cell transplantation.

Complete substitution of cyclophosphamide by fludarabine and ATG in a busulfan-based preparative regimen for children and adolescents with β-thalassemia.

Modification of the Bu/Cy myeloablative regimen using daily parenteral busulfan: reduced toxicity without the need for pharmacokinetic monitoring.

CD8+T-cell-depleted, matched unrelated donor, allogeneic bone marrow transplantation for advanced AML using busulfan-based preparative regimens.

Overexpression of Glutathione-S-Transferase, MGSTII, Confers Resistance to Busulfan and Melphalan.

Intravenous busulfan in children prior to stem cell transplantation: study of pharmacokinetics in association with early clinical outcome and toxicity.

High-dose busulfan, cyclophosphamide, and etoposide does not improve outcome of allogeneic stem cell transplantation compared to BuCy2 in patients with acute myeloid leukemia.

Possible role of high-dose busulfan in second reciprocal transplant between brother and sister for resistant acute leukemia.

اتصل بنا

اتبع